title: Conventional stepwise vs. vital capacity rapid inhalation induction at two concentrations of sevoflurane.
abstract: OBJECTIVE
  A multicentre study was conducted to compare three methods of inhalation induction with sevoflurane in adult premedicated patients.
  
  
  METHODS
  One-hundred-and-twenty-five adult patients of ASA I-II were scheduled for short elective surgical procedures (< 90 min) under general anaesthesia with spontaneous ventilation of the lungs via a laryngeal mask airway. Patients were randomly assigned to one of three groups: conventional stepwise inhalation induction group (Group C) or vital capacity rapid inhalation induction groups at 4.5% (Group VC4.5) or at 8% sevoflurane (Group VC8). Before anaesthetic induction, fentanyl 1 micro kg(-1) was given and the face mask applied with the anaesthetic breathing system primed with sevoflurane 4.5% or 8% in the respective vital capacity groups. Loss of eyelash reflex, time to cessation of finger tapping, laryngeal mask insertion, side-effects and adequacy of induction were recorded.
  
  
  RESULTS
  The time to loss of eyelash reflex was significantly shorter in both vital capacity groups vs. the control group: VC8: 68 +/- 7 s; and VC4.5: 94 +/- 6.5 s vs. C: 118 +/- 6.4s (P < 0.0001). Significant differences were found in all pairwise comparisons for time to cessation of tapping: Group VC8 (62 +/- 7 s), Group VC4.5 (85 +/- 6 s) and Group C (116 +/- 6 s; P < 0.0001). The time to laryngeal mask insertion was significantly shorter in the Group VC8 (176 +/- 13 s) compared with the other two groups, Group VC4.5 (219 +/- 13 s) and Group C (216 +/- 9 s). There were no significant differences in the incidence of side-effects between the three groups.
  
  
  CONCLUSIONS
  Inhalation induction of anaesthesia with sevoflurane with the three techniques tested is safe, reliable and well accepted by the patients. The vital capacity rapid inhalation group primed with sevoflurane 8% was the fastest method with no relevant side-effects.
authors.affiliation: Hospital La Milagrosa, Department of Anaesthesiology, Madrid, Spain. rmlarrauri@adv.es
authors.forename: R
authors.initials: R
authors.lastname: Martín-Larrauri
authors.forename: F
authors.initials: F
authors.lastname: Gilsanz
authors.forename: J
authors.initials: J
authors.lastname: Rodrigo
authors.forename: P
authors.initials: P
authors.lastname: Vila
authors.forename: M
authors.initials: M
authors.lastname: Ledesma
authors.forename: C
authors.initials: C
authors.lastname: Casimiro
mesh_terms: D000328:Adult; D000368:Aged; D000769:Anesthesia, Inhalation / Q000379:methods*; D018685:Anesthetics, Inhalation / Q000008:administration & dosage* / Q000009:adverse effects; D018686:Anesthetics, Intravenous / Q000008:administration & dosage; D001767:Blinking / Q000187:drug effects; D017558:Elective Surgical Procedures; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage; D005385:Fingers / Q000502:physiology; D006801:Humans; D017214:Laryngeal Masks; D008297:Male; D016555:Matched-Pair Analysis; D008738:Methyl Ethers / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D009043:Motor Activity / Q000187:drug effects; D011292:Premedication; D000077149:Sevoflurane; D013997:Time Factors; D014797:Vital Capacity / Q000502:physiology*
chemical_list: D018685:Anesthetics, Inhalation; D018686:Anesthetics, Intravenous; D008738:Methyl Ethers; D000077149:Sevoflurane; D005283:Fentanyl